Early Stimulant Treatment and ADHD

[Guest guest]

This Article

•

Full text

•

PDF

•

Send to a friend

•

Save in My Folder

•

Save to citation manager

•

Permissions

Citing Articles

•

Contact me when this article is cited

Related Content

•

Similar articles in this journal

Topic Collections

•

Adolescent Medicine

•

Pediatrics, Other

•

Psychiatry

•

Attention Deficit Hyperactivity Disorder

•

Substance Abuse/ Alcoholism

•

Tobacco

•

Drug Therapy

•

Alert me on articles by topic

Effect of Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in Adolescents E. Wilens, MD; on, BA; C. Monuteaux, ScD; V. Faraone, PhD; Schillinger, BA; Westerberg, BA; ph Biederman, MD

Arch Pediatr Adolesc Med. 2008;162(10):916-921.

Objective To examine the effects of early stimulant treatment on subsequent risk for cigarette smoking and substance use disorders (SUDs) in adolescents with attention-deficit/hyperactivity disorder (ADHD).

Design Case-controlled, prospective, 5-year follow-up study.

Setting Massachusetts General Hospital, Boston.

Participants Adolescents with and without ADHD from psychiatric and pediatric sources. Blinded interviewers determined all diagnoses using structured interviews.

Intervention Naturalistic treatment exposure with psychostimulants for ADHD.

Main Outcome Measures We modeled time to onset of SUDs and smoking as a function of stimulant treatment.

Results We ascertained 114 subjects with ADHD (mean age at follow-up, 16.2 years) having complete medication and SUD data; 94 of the subjects were treated with stimulants. There were no differences in SUD risk factors between naturalistically treated and untreated groups other than family history of ADHD. We found no increased risks for cigarette smoking or SUDs associated with stimulant therapy. We found significant protective effects of stimulant treatment on the development of any SUD (hazard ratio

---

, 0.27; 95% confidence interval [CI], 0.13-0.60; 2113 = 10.57, P = .001) and cigarette smoking (HR, 0.28; 95% CI, 0.14-0.60; 2111 = 10.05, P = .001) that were maintained when controlling for conduct disorder. We found no effects of time to onset or duration of stimulant therapy on subsequent SUDs or cigarette smoking in subjects with ADHD.

Conclusion Stimulant therapy does not increase but rather reduces the risk for cigarette smoking and SUDs in adolescents with ADHD.

Author Affiliations: Pediatric Psychopharmacology Program, Massachusetts General Hospital, Harvard Medical School, Boston (Drs Wilens, Monuteaux, and Biederman, Mr on, and Mss Schillinger and Westerberg); and Departments of Psychiatry and of Neuroscience and Physiology, State University of New York Upstate Medical University, Syracuse (Dr Faraone).

New MapQuest Local shows what's happening at your destination. Dining, Movies, Events, News more. Try it out!